Hims

Hims & Hers Health, Inc., founded in 2017 and operating under the ticker NYSE: HIMS, is a consumer-first, multi-specialty telehealth company. Headquartered in San Francisco, California, it leverages a direct-to-consumer digital platform to connect patients with licensed healthcare professionals. This innovative approach facilitates consultations, prescription fulfillment, and personalized treatment plans for a wide array of health and wellness needs. The company's foundation is built on providing accessible and convenient healthcare solutions.

The company's comprehensive service offerings span critical areas including sexual health, hair care, dermatology, mental health, weight management, hormone health, and primary care for both men and women. Patients can access prescription medications, over-the-counter products, cosmetics, supplements, and laboratory testing services via its website and mobile application. Hims & Hers also integrates artificial intelligence and machine learning to enhance personalized treatment recommendations and patient outcomes. To understand the driving force behind these innovations, one can Meet Hims's team.

With an employee range of 1,000-5,000 employees, Hims & Hers maintains a significant operational footprint. Beyond its presence in the United States, the company has expanded internationally into the United Kingdom, Canada, Germany, Ireland, France, and Spain. This global reach is supported by a substantial revenue of $2.4B. For detailed financial performance and market standing, interested parties can Explore financial highlights. Hims & Hers competes in the rapidly evolving digital health landscape, offering a broad spectrum of services designed for modern consumer healthcare needs.